Coronavirus channel feed – Endpoints News

Coronavirus channel feed

Covid-19 roundup: Generic Merck pill to be made for lower-income countries; Gavi says it needs a $5B boost — report

4 years ago

Covid-19 roundup: Pfizer expands into France; Omicron-specific version of Moderna's booster coming soon

4 years ago

Covid-19 roundup: Supreme Court blocks Biden administration's vaccine mandate for large businesses; South Africa study suggests J&J booster is 85% effective against hospitalization

4 years ago

Covid-19 roundup: AstraZeneca touts booster as effective against Omicron; Africa CDC reportedly in talks to buy Paxlovid

4 years ago

With new Omicron data, Adagio halts trials for vaunted Covid antibody but sees a path ahead

4 years ago

Covid-19 roundup: FDA addresses risk of excessive bleeding after J&J vaccine; Novavax vaccine gets OK in South Korea

4 years ago

How a tiny Swiss lab and two old blood samples created one of the only effective drugs against Omicron (and why we have so little of it)

4 years ago

Woodcock defends FDA's response to Omicron before Senate health committee

4 years ago

Covid-19 roundup: US buys more of the only antibody that works against Omicron; BioNTech taps AI to detect new variants faster

4 years ago

Novartis snaps up the rights to a Covid-19 antiviral after seeing mid-stage results. So where are the data?

4 years ago

Covid-19 roundup: FDA shortens interval for Moderna booster dose to 5 months; Moderna CEO says another booster could be necessary this fall — report

4 years ago

FDA loses FOIA suit over Pfizer vaccine documents, must release 55,000 pages per month

4 years ago

Covid-19 roundup: Investors call to link CEO salaries to vaccine access; Why there aren't more initial supplies of the Pfizer pill

4 years ago

US restarts shipments of two mAbs that don't work against Omicron as Merck pills see wider distribution

4 years ago

Covid-19 roundup: FDA authorizes Pfizer-BioNTech booster for 12-to-15-year-olds; Early results suggest antivirals may hold up against Omicron

4 years ago

Covid-19 manufacturing roundup: Indian manufacturer waives vaccine protections for migrants; EMA gives go-ahead for French J&J production site

4 years ago

FDA authorizes new Merck Covid-19 pill despite scientists' concerns on its mechanism of action

4 years ago

Covid-19 roundup: Novavax says vaccine shows 'broad cross-reactivity' against Omicron; France cancels order on Merck’s antiviral pill — report

4 years ago

FDA authorizes the first at-home pills from Pfizer to treat Covid-19

4 years ago

Covid-19 roundup: Questions remain on US supplies of Pfizer, Merck pills as UK ramps up; Israel to go for a fourth dose for those over 60

4 years ago

Covid-19 roundup: FDA to sign off on Merck, Pfizer pills this week — report; Broad Institute finds rise of Omicron through CRISPR diagnostics

4 years ago

With few treatment options for Omicron, convalescent plasma is ready for a comeback — will the FDA be on board with outpatient use?

4 years ago

Covid-19 roundup: Novavax finally receives the go-ahead in Europe for its vaccine; CDC struggles to track Omicron

4 years ago

Truce: Moderna backs down in patent fight with NIH as it touts early booster data against Omicron

4 years ago

First page Previous page 14 15 161718 19 20 Next page Last page